Deka Bank Deutsche Girozentrale Coherus Bio Sciences, Inc. Transaction History

Deka Bank Deutsche Girozentrale

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$3.79 - $8.3 $12,886 - $28,220	3,400 Added 2.92%	120,000 $498,000
Q1 2022 Apr 28, 2022	BUY	$10.92 - $16.41 $115,752 - $173,946	10,600 Added 10.0%	116,600 $1.5 Million
Q4 2021 Feb 02, 2022	BUY	$15.81 - $18.99 $45,849 - $55,070	2,900 Added 2.81%	106,000 $1.8 Million
Q3 2021 Oct 22, 2021	BUY	$12.68 - $17.79 $380,400 - $533,700	30,000 Added 41.04%	103,100 $1.69 Million
Q1 2021 Apr 28, 2021	BUY	$14.42 - $21.39 $504,700 - $748,650	35,000 Added 91.86%	73,100 $1.07 Million
Q4 2020 Mar 12, 2021	SELL	$16.56 - $18.94 $31,463 - $35,986	-1,900 Reduced 4.75%	38,100 $645,000
Q3 2020 Oct 29, 2020	BUY	$17.41 - $19.89 $696,400 - $795,600	40,000 New	40,000 $733,000
Q4 2019 Feb 04, 2020	SELL	$16.33 - $21.37 $676,061 - $884,718	-41,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $717,200 - $1.03 Million	-44,000 Reduced 51.52%	41,400 $848,000
Q2 2019 Aug 01, 2019	BUY	$13.1 - $22.1 $839,710 - $1.42 Million	64,100 Added 300.94%	85,400 $1.84 Million
Q1 2019 May 10, 2019	BUY	$8.38 - $15.5 $30,168 - $55,800	3,600 Added 20.34%	21,300 $426,000
Q4 2018 Feb 12, 2019	SELL	$8.65 - $16.28 $31,140 - $58,608	-3,600 Reduced 16.9%	17,700 $156,000
Q3 2018 Nov 09, 2018	SELL	$14.45 - $20.25 $8,670 - $12,150	-600 Reduced 2.74%	21,300 $0
Q1 2018 May 03, 2018	SELL	$9.1 - $13.7 $4,550 - $6,850	-500 Reduced 2.23%	21,900 $245,000
Q3 2017 Nov 06, 2017	BUY	$11.1 - $14.5 $248,640 - $324,800	22,400	22,400 $258,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.